 |
|
Home | Globus Medical Downgraded to “Underperform” at Zacks (GMED) |
 |
Globus Medical Downgraded to “Underperform” at Zacks (GMED)
|
 |
- October 02, 2014
-
Globus Medical (NASDAQ:GMED) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research report issued to clients and investors on Wednesday. They currently have a $18.70 price target on the stock. Zacks‘s price objective would suggest a potential downside of 4.93% from the stock’s previous close. A number of other […]This article (Globus Medical Downgraded to “Underperform” at Zacks (GMED)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2014/10/01/globus-medical-downgraded-to-underperform-at-zacks-gmed/
|
 |
|
 |
|
 |
